Abstract Positron Emission Tomography (PET) experienced accelerated development and
has become an established method for medical research and clinical routine diagnostics on …

Introduction: Recently, there have been a number of advances in imaging pancreatic
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …

Human cancer cells overexpress many peptide receptors as molecular targets.
Radiolabeled peptides that bind with high affinity and specificity to the receptors on tumor …

Purpose Given the bone tropism of prostate cancer, conventional imaging modalities poorly
identify or quantify metastatic disease. 89 Zr-huJ591 positron emission tomography (PET) …

Introduction: Despite remarkable advances in tumor treatment, many patients still die from
common tumors (breast, prostate, lung, CNS, colon, and pancreas), and thus, new …

OBJECTIVE. Recent advances in the fundamental understanding of the complex biology of
prostate cancer have provided an increasing number of potential targets for imaging and …

Radiolabelled receptor-binding peptides targeting receptors (over) expressed on tumour
cells are widely under investigation for tumour diagnosis and therapy. The concept of using …

Ambient fine particulate matter (PM 2.5) and high-fat diet (HFD) are linked to the
development of atherosclerosis. However, there is still unknown about the PM 2.5-induced …

A novel radiofluorinated derivative of bombesin, 18 F-AmBF 3-MJ9, was synthesized and
evaluated for its potential to image prostate cancer by targeting the gastrin releasing peptide …

Radiolabeled bombesin (BBN) analogs that bind to the gastrin-releasing peptide receptor
(GRPR) represent a topic of active investigation for the development of molecular probes for …